$ Value
$0
Shares
117,000
Price
$0
Filed
Feb 3
Insider
Name
Johnson Anne Nagengast
Title
Chief Financial Officer
CIK
0001976640
Roles
Transaction Details
Transaction Date
2026-01-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
117,000
Footnotes
The stock option vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on January 1, 2027 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter. | Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.
Filing Info
Other Insiders at ATAI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Faerm Michael E.
Chief Financial Officer
|
— | — | 2026-03-11 |
| Angermayer Christian | — | — | 2026-04-08 |
|
Rao Srinivas
See remarks
|
— | — | 2026-01-30 |
|
Johnson Anne Nagengast
Chief Financial Officer
|
— | — | 2026-01-30 |
|
Kochendoerfer Gerd
Chief Operating Officer
|
— | — | 2026-01-30 |
|
Short Glenn Frank
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
Craig Kevin James
Chief Medical Officer
|
— | $568K | 2026-04-20 |
|
Barrett Christopher Ryan Cave
See remarks
|
— | — | 2026-01-30 |